Treatment of Early Stage (T1 / Small T2) Lip Cancer at the Commissure
This protocol covers the management of malignant neoplasm arising at the commissure of the lip in early disease: T1 tumours, or small T2 lesions measuring 2 cm or smaller in greatest dimension.
Clinical scenario
Early stage (T1 / small T2) malignant neoplasm of the commissure of lip — a small lip lesion 2 cm or smaller. Early stage cancer can be treated equally well by surgery or radiation therapy. Small lesions are amenable to management by simple surgical excision and primary closure.
Treatment Approach
For locally recurrent disease in this setting, full restaging is undertaken followed by curative re-treatment. The protocol specifies a surgical option as well as an external beam or localised radiotherapy option where available — with defined candidacy criteria and sequencing that remain within the full protocol.
References
DOI: 10.1017/S0022215116000499
Early stage cancer can be treated equally well by surgery or radiation therapy.
Small lesions are managed by simple surgical excision and primary closure.
Patients with locally recurrent disease should be fully restaged and assessed for consideration of curative treatment in the form of repeat surgery, possible EBRT or brachytherapy if available.
Even re-excision because of local failure leads to salvage in 75–80 per cent of cases.
View source ↗